Department of Clinical Medicine, School of Health and Medical Science, Örebro University, Örebro, Sweden.
Int J Mol Med. 2012 Sep;30(3):697-702. doi: 10.3892/ijmm.2012.1026. Epub 2012 Jun 12.
Interleukin (IL)-1β is known to be activated by the inflammasome. Inflammasome activities depend on a plethora of moieties including NLRP3 and CARD8, which have been reported to be associated with several inflammatory diseases. Aortic smooth muscle cells (AOSMCs) were transfected with siRNA targeting the NLRP3 and CARD8 genes, followed by tumor necrosis factor-α (TNF-α) treatment. We found that TNF-α induces IL-1β, IL-1Ra and NLRP3 genes but not CARD8. Silencing of the NLRP3 gene significantly decreased IL-1β expression and release, the IL-1Ra expression showed a borderline non-significant increment, while CARD8 knockdown did not affect the IL-1β and IL-1Ra mRNA expression or IL-1β protein release. Our results suggest that mainly NLRP3 plays a role in the regulation of IL-1β expression and release in AOSMC and could be a potential future target for the treatment of atherosclerosis and other inflammatory diseases.
白细胞介素 (IL)-1β 已知可被炎性小体激活。炎性小体的活性依赖于多种分子,包括 NLRP3 和 CARD8,据报道它们与多种炎症性疾病有关。用靶向 NLRP3 和 CARD8 基因的 siRNA 转染主动脉平滑肌细胞 (AOSMC),然后用肿瘤坏死因子-α (TNF-α) 处理。我们发现 TNF-α 诱导 IL-1β、IL-1Ra 和 NLRP3 基因的表达,但不诱导 CARD8 基因的表达。沉默 NLRP3 基因可显著降低 IL-1β 的表达和释放,IL-1Ra 的表达呈边缘非显著增加,而 CARD8 敲低不影响 IL-1β 和 IL-1Ra mRNA 的表达或 IL-1β 蛋白的释放。我们的结果表明,主要是 NLRP3 在调节 AOSMC 中 IL-1β 的表达和释放中起作用,可能是治疗动脉粥样硬化和其他炎症性疾病的潜在未来靶点。